ZVSAOTCPharmaceutical PreparationsFiscal year ends December 31
ZyVersa Therapeutics, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 13, 2026
$0.05+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $388.60K
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about ZyVersa Therapeutics from other investors
No posts about ZVSA yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.